Legal Representation
Attorney
Holly A. Coldiron
USPTO Deadlines
Next Deadline
0 days remaining
Notice of Publication
Due Date
July 24, 2025
Extension Available
Until August 24, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
13 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 24, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 24, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 18, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 20, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 16, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 16, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 16, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 26, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 26, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 26, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 20, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 14, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Aug 14, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and therapeutic agents for the treatment of nephrological and systemic diseases, namely, inborn errors of metabolism, gout, hypertension, type 2 diabetes, chronic heart failure, nephrolithiasis, and endocrine disorders; Pharmaceutical preparations, namely, oligonucleotides, siRNA and antisense RNA (asRNA) for medical use and use in the treatment of nephrological and systemic diseases, namely, inborn errors of metabolism, gout, hypertension, type 2 diabetes, chronic heart failure, nephrolithiasis, and endocrine disorders
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"